Alnylam Pharmaceuticals, Inc. (ALNY)
328.73
-2.14
(-0.65%)
USD |
NASDAQ |
Apr 01, 16:00
328.92
+0.19
(+0.06%)
After-Hours: 20:00
Alnylam Pharmaceuticals Research and Development Expense (TTM) : 1.320B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.25B |
| Eli Lilly & Co. | 13.34B |
| Ionis Pharmaceuticals, Inc. | 914.12M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Bristol Myers Squibb Co. | 9.492B |